本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LifeStance Health Group, Inc.

12.28
+0.12000.99%
盤後12.320.0400+0.33%19:30 EDT
成交量:362.40萬
成交額:4,399.55萬
市值:46.92億
市盈率:95.31
高:12.30
開:12.19
低:11.92
收:12.16
52周最高:12.97
52周最低:4.77
股本:3.82億
流通股本:2.49億
量比:1.31
換手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):0.1288
每股收益(LYR):0.0200
淨資產收益率:3.43%
總資產收益率:2.32%
市淨率:3.18
市盈率(LYR):614.00

資料載入中...

2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities